Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2002 1
2006 1
2007 1
2010 1
2012 1
2013 2
2014 2
2017 1
2018 1
2019 1
2020 1
2023 2
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

13 results

Results by year

Filters applied: . Clear all
Page 1
Efficacy and Safety of Degludec versus Glargine in Type 2 Diabetes.
Marso SP, McGuire DK, Zinman B, Poulter NR, Emerson SS, Pieber TR, Pratley RE, Haahr PM, Lange M, Brown-Frandsen K, Moses A, Skibsted S, Kvist K, Buse JB; DEVOTE Study Group. Marso SP, et al. N Engl J Med. 2017 Aug 24;377(8):723-732. doi: 10.1056/NEJMoa1615692. Epub 2017 Jun 12. N Engl J Med. 2017. PMID: 28605603 Free PMC article. Clinical Trial.
[Treatment of type 2 diabetes in the elderly].
Gómez Huelgas R, Díez-Espino J, Formiga F, Lafita Tejedor J, Rodríguez Mañas L, González-Sarmiento E, Menéndez E, Sangrós J; en nombre del Grupo de Trabajo para el Documento de Consenso sobre el tratamiento de la diabetes tipo 2 en el anciano. Gómez Huelgas R, et al. Med Clin (Barc). 2013 Feb 2;140(3):134.e1-134.e12. doi: 10.1016/j.medcli.2012.10.003. Epub 2012 Nov 28. Med Clin (Barc). 2013. PMID: 23199835 Spanish.
Position statement on efficiency of technologies for diabetes management.
Martín-Vaquero P, Martínez-Brocca MA, García-López JM; Grupo de Trabajo de Nuevas Tecnologías de la Sociedad Española; Grupo de Diabetes de la Sociedad Española de Endocrinología y Nutrición; Sociedad Española de Endocrinología Pediátrica. Martín-Vaquero P, et al. Endocrinol Nutr. 2014 Dec;61(10):e45-63. doi: 10.1016/j.endonu.2014.08.003. Endocrinol Nutr. 2014. PMID: 25453400 English, Spanish.
Prevention of overweight and obesity: a Spanish approach.
Aranceta J, Pérez-Rodrigo C, Serra-Majem L, Bellido D, de la Torre ML, Formiguera X, Moreno B. Aranceta J, et al. Among authors: de la torre ml. Public Health Nutr. 2007 Oct;10(10A):1187-93. doi: 10.1017/S1368980007000699. Public Health Nutr. 2007. PMID: 17903329 Free article. Review.
Physical activity patterns in type 1 diabetes in Spain: The SED1 study.
Gómez-Peralta F, Menéndez E, Conde S, Conget I, Novials A; SED and SED1 study investigators. Gómez-Peralta F, et al. BMC Sports Sci Med Rehabil. 2023 Jul 26;15(1):92. doi: 10.1186/s13102-023-00695-3. BMC Sports Sci Med Rehabil. 2023. PMID: 37491278 Free PMC article.
[Practical management of oral antidiabetics in patients with renal disease].
Alcazar R, Gonzalez Albarran O, Honorato J, Robles NR, Acha J, de Alvaro F, Fernandez Gallego V, Gomez Garcia P, Lopez de la Torre M, Martinez Castelao A, Romero R. Alcazar R, et al. Among authors: lopez de la torre m. Nefrologia. 2006;26(5):538-58. Nefrologia. 2006. PMID: 17117897 Free article. Review. Spanish. No abstract available.
Descriptive study of a clinical and educational telemedicine intervention in patients with diabetes receiving glargine 300 U/ml (Toujeo) in Spain: results of the T-Coach programme.
Bellido V, Morales C, Garach AM, Almeida JMG, Morera JLF, Aguilera BG, de la Torre ML, Bellido D. Bellido V, et al. Among authors: de la torre ml. Drugs Context. 2023 May 24;12:2023-1-1. doi: 10.7573/dic.2023-1-1. eCollection 2023. Drugs Context. 2023. PMID: 37261244 Free PMC article.
Efficacy and safety of a fixed-ratio combination of insulin degludec and liraglutide (IDegLira) compared with its components given alone: results of a phase 3, open-label, randomised, 26-week, treat-to-target trial in insulin-naive patients with type 2 diabetes.
Gough SC, Bode B, Woo V, Rodbard HW, Linjawi S, Poulsen P, Damgaard LH, Buse JB; NN9068-3697 (DUAL-I) trial investigators. Gough SC, et al. Lancet Diabetes Endocrinol. 2014 Nov;2(11):885-93. doi: 10.1016/S2213-8587(14)70174-3. Epub 2014 Sep 1. Lancet Diabetes Endocrinol. 2014. PMID: 25190523 Clinical Trial.
13 results